- Home
- TSEM vs RYTM Comparison
TSEM vs RYTM Comparison
Compare TSEM & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSEM
- RYTM
- Stock Information
- Founded
- TSEM 1993
- RYTM 2008
- Country
- TSEM Israel
- RYTM United States
- Employees
- TSEM N/A
- RYTM N/A
- Industry
- TSEM Semiconductors
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- TSEM Technology
- RYTM Health Care
- Exchange
- TSEM Nasdaq
- RYTM Nasdaq
- Market Cap
- TSEM 4.6B
- RYTM 4.3B
- IPO Year
- TSEM 1994
- RYTM 2017
- Fundamental
- Price
- TSEM $39.48
- RYTM $61.99
- Analyst Decision
- TSEM Strong Buy
- RYTM Strong Buy
- Analyst Count
- TSEM 3
- RYTM 12
- Target Price
- TSEM $60.00
- RYTM $76.75
- AVG Volume (30 Days)
- TSEM 456.0K
- RYTM 525.0K
- Earning Date
- TSEM 07-23-2025
- RYTM 08-05-2025
- Dividend Yield
- TSEM N/A
- RYTM N/A
- EPS Growth
- TSEM N/A
- RYTM N/A
- EPS
- TSEM 1.80
- RYTM N/A
- Revenue
- TSEM $1,467,054,000.00
- RYTM $136,863,000.00
- Revenue This Year
- TSEM $10.30
- RYTM $37.56
- Revenue Next Year
- TSEM $11.17
- RYTM $74.99
- P/E Ratio
- TSEM $22.17
- RYTM N/A
- Revenue Growth
- TSEM 5.22
- RYTM 48.88
- 52 Week Low
- TSEM $28.64
- RYTM $39.46
- 52 Week High
- TSEM $55.31
- RYTM $69.89
- Technical
- Relative Strength Index (RSI)
- TSEM 48.40
- RYTM 47.67
- Support Level
- TSEM $37.48
- RYTM $60.70
- Resistance Level
- TSEM $40.40
- RYTM $62.65
- Average True Range (ATR)
- TSEM 1.32
- RYTM 2.39
- MACD
- TSEM -0.30
- RYTM -0.52
- Stochastic Oscillator
- TSEM 37.11
- RYTM 14.04
About TSEM Tower Semiconductor Ltd.
Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs), based on the design specifications of customers. The company's line of integrated circuits is incorporated into a range of products and markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. It produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. The company has a geographical presence in the USA, Japan, Asia (other than Japan), and Europe.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.